DOPTELET

AkaRx, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 13, 2025
Approval ID: e2d5960d-6c18-46cc-86bd-089222b09852
Products: 2 registered
Version: 17

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DOPTELET safely and effectively. See full prescribing information for DOPTELET. DOPTELET (avatrombopag ) tablets, for oral useDOPTELET® SPRINKLE (avatrombopag) oral granules Initial U.S. Approval: 2018

Quick Stats

Total Products2

Labelers2

Label Sections41

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.